Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Monday, March 9, 2020
FDA In Brief: FDA Releases Final Report of Talc-containing Cosmetic Products Tested for Asbestos
The following quote is attributed to Susan Mayne, Ph.D., director of the Center for Food Safety and Applied Nutrition
“The FDA is committed to keeping consumers safe from potentially contaminated cosmetic products. As part of this effort, in September 2018, the agency awarded AMA Analytical Services, Inc. (AMA) a one-year contract to test certain talc-containing cosmetic products for the presence of asbestos. We have taken and will continue to take swift action when we determine a cosmetic product is not safe.
“There is general agreement among U.S. federal agencies and the World Health Organization that there is no known safe level of asbestos exposure. Earlier this month during a public meeting, the FDA gathered input from federal partners, industry experts and the public to support the development of standardized testing, methodologies, terminology and criteria that can be applied to characterize and measure asbestos and other potentially harmful elongate mineral particles that may be present as ...